Direxion Daily S&P Biotech Bull 3x Shares Rating $71.98 +0.93 (+1.31%) Closing price 04:10 PM EasternExtended Trading$72.14 +0.16 (+0.22%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsBuy This Stock Direxion Daily S&P Biotech Bull 3x Shares Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.LABU Aggregate RatingModerate Buy 2.79Holdings in LABU have an aggregate rating of Moderate Buy based on 1,521 analyst ratings issued in the past year covering 137 companies (72.5% of the portfolio).LABU Aggregate Price Target$71.98High Prediction$71.98Average Prediction$71.98Low Prediction$71.98Holdings in LABU have an aggregate price target of $71.98 and a range of $71.98 to $71.98 covering 137 companies (72.5% of the portfolio).LABU Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy62 Buy rating(s)Moderate Buy64 Moderate Buy rating(s)Hold10 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily S&P Biotech Bull 3x Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 100 LABU Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.25%GILDGilead Sciences$111.16+1.7%4.6001 of 5 stars2.72$105.12 -5.4%29Analyst ForecastPositive News2.22%ABBVAbbVie$202.79+0.7%4.5545 of 5 stars2.92$211.45 4.3%25Positive News2.09%AMGNAmgen$305.77+0.0%4.4645 of 5 stars2.46$314.04 2.7%24Positive News1.97%VRTXVertex Pharmaceuticals$502.55+0.5%3.8819 of 5 stars2.65$506.70 0.8%26Positive News1.96%BMRNBioMarin Pharmaceutical$72.83+1.9%4.929 of 5 stars2.71$94.00 29.1%24Options VolumeAnalyst Revision1.85%INSMInsmed$77.69+1.5%4.0146 of 5 stars3.00$94.00 21.0%16News Coverage1.80%HALOHalozyme Therapeutics$64.48+1.0%4.2921 of 5 stars2.60$62.78 -2.6%10Positive News1.74%ALNYAlnylam Pharmaceuticals$271.02+0.7%4.2621 of 5 stars2.76$312.30 15.2%25Analyst Upgrade1.71%INCYIncyte$60.68-0.9%4.6513 of 5 stars2.21$74.88 23.4%19Analyst Forecast1.68%TGTXTG Therapeutics$40.20-1.4%3.0537 of 5 stars2.83$40.67 1.2%6Positive News1.63%BIIBBiogen$140.33-1.5%4.9128 of 5 stars2.43$213.33 52.0%30Positive News1.61%REGNRegeneron Pharmaceuticals$635.83-0.7%4.8454 of 5 stars2.76$973.13 53.0%25Short Interest ↑Positive News1.56%NBIXNeurocrine Biosciences$114.00-0.4%4.9289 of 5 stars2.83$165.38 45.1%23Analyst ForecastNews CoveragePositive News1.56%NTRANatera$148.30-1.0%3.1417 of 5 stars3.00$178.12 20.1%16Short Interest ↑Positive News1.54%UTHRUnited Therapeutics$308.02-0.9%4.9367 of 5 stars2.67$388.25 26.0%12Insider TradeShort Interest ↓Positive News1.47%PCVXVaxcyte$70.77+3.2%2.0593 of 5 stars3.00$147.50 108.4%9News CoveragePositive News1.47%MRNAModerna$32.12+2.0%4.1947 of 5 stars2.04$59.00 83.7%241.46%MDGLMadrigal Pharmaceuticals$337.27+1.0%3.5467 of 5 stars2.80$378.44 12.2%10Positive News1.44%SRPTSarepta Therapeutics$71.81-1.5%4.8447 of 5 stars2.83$167.41 133.1%23Positive News1.25%EXASExact Sciences$44.99+0.2%4.5924 of 5 stars2.90$70.83 57.4%20Positive News1.25%ADMAADMA Biologics$20.28+2.9%2.4301 of 5 stars3.25$22.50 10.9%4Positive News1.10%BBIOBridgeBio Pharma$36.40+0.8%4.6803 of 5 stars2.91$52.90 45.3%11Analyst ForecastPositive News1.10%VKTXViking Therapeutics$26.13-0.8%4.3394 of 5 stars3.00$95.18 264.3%12Analyst Forecast1.09%BPMCBlueprint Medicines$89.73-1.1%2.78 of 5 stars2.70$124.95 39.3%23Insider TradePositive News1.07%IONSIonis Pharmaceuticals$31.72+0.7%4.3401 of 5 stars2.70$59.44 87.4%20Analyst ForecastNews Coverage1.06%EXELExelixis$36.84-0.5%4.5573 of 5 stars2.50$37.59 2.0%20Upcoming EarningsAnalyst ForecastNews CoveragePositive News1.01%ROIVRoivant Sciences$10.48+0.4%2.3739 of 5 stars3.00$17.10 63.2%6Insider Trade1.00%CYTKCytokinetics$42.99-1.5%3.9937 of 5 stars2.94$82.00 90.7%180.96%ALKSAlkermes$33.53-0.5%4.629 of 5 stars2.69$39.38 17.5%13Analyst ForecastNews CoveragePositive NewsGap Up0.95%CRSPCRISPR Therapeutics$38.04-2.9%3.3008 of 5 stars2.48$73.11 92.2%210.92%RVMDRevolution Medicines$38.10+1.0%4.1827 of 5 stars3.08$66.31 74.0%13Positive News0.83%SWTXSpringWorks Therapeutics$47.49+2.2%2.3615 of 5 stars3.00$73.20 54.1%5Positive News0.82%SMMTSummit Therapeutics$20.60+3.6%2.8451 of 5 stars3.00$35.44 72.1%10Analyst UpgradeNews Coverage0.80%APLSApellis Pharmaceuticals$24.28+2.1%4.3561 of 5 stars2.63$45.53 87.5%190.78%RNAAvidity Biosciences$32.56+1.6%2.3366 of 5 stars3.00$66.69 104.8%130.72%PTGXProtagonist Therapeutics$49.44-0.2%3.5985 of 5 stars3.00$62.56 26.5%9Positive News0.69%ACLXArcellx$68.51-2.3%2.2716 of 5 stars3.13$108.46 58.3%15Positive News0.66%KRYSKrystal Biotech$182.75-2.3%4.7076 of 5 stars3.00$220.00 20.4%8Positive News0.60%NUVLNuvalent$73.62-0.4%2.2782 of 5 stars2.92$113.10 53.6%13Positive News0.56%PTCTPTC Therapeutics$54.99-0.6%3.4859 of 5 stars2.53$64.00 16.4%15Positive News0.54%RAREUltragenyx Pharmaceutical$38.89+2.4%4.4772 of 5 stars2.93$92.79 138.6%14Analyst ForecastPositive News0.52%BHVNBiohaven$28.35-1.8%3.9185 of 5 stars3.07$62.77 121.4%150.50%TWSTTwist Bioscience$41.58-0.7%3.9365 of 5 stars2.70$54.40 30.8%100.48%RXRXRecursion Pharmaceuticals$5.97-3.2%2.2164 of 5 stars2.40$8.25 38.2%5Gap Down0.47%DVAXDynavax Technologies$13.72+1.0%4.3127 of 5 stars2.33$21.50 56.7%3Options VolumePositive News0.46%TVTXTravere Therapeutics$20.37-2.0%2.8232 of 5 stars2.93$30.62 50.3%14News CoveragePositive News0.44%AKROAkero Therapeutics$43.58+0.7%4.1636 of 5 stars3.00$76.29 75.0%90.44%SLNOSoleno Therapeutics$67.39+37.6%4.6647 of 5 stars3.25$91.17 35.3%8Analyst ForecastNews CoverageGap UpHigh Trading Volume0.42%CLDXCelldex Therapeutics$19.98+2.1%1.7606 of 5 stars2.89$54.33 171.9%90.42%ARQTArcutis Biotherapeutics$16.09-2.3%2.6873 of 5 stars2.83$18.80 16.8%6Short Interest ↓Positive News0.40%NVAXNovavax$7.26-1.8%3.8082 of 5 stars2.43$18.00 147.9%7Analyst Revision0.40%ARDXArdelyx$5.14+2.0%4.3892 of 5 stars3.00$10.95 113.0%120.40%FOLDAmicus Therapeutics$8.59+0.8%4.2937 of 5 stars2.78$16.75 95.0%9Positive News0.39%CRNXCrinetics Pharmaceuticals$34.90+1.1%4.3886 of 5 stars2.92$73.00 109.2%13Analyst Forecast0.38%BEAMBeam Therapeutics$22.19+1.3%3.4709 of 5 stars3.00$50.20 126.2%13Short Interest ↑0.38%VCYTVeracyte$31.10+0.2%4.5636 of 5 stars2.70$43.40 39.5%10Analyst ForecastNews Coverage0.37%SRRKScholar Rock$33.36+3.7%3.5081 of 5 stars3.14$40.86 22.5%7Analyst ForecastInsider Trade0.37%VRDNViridian Therapeutics$14.67+3.6%1.3338 of 5 stars2.75$35.70 143.4%12Positive News0.35%RYTMRhythm Pharmaceuticals$53.49-1.5%4.442 of 5 stars2.92$69.46 29.9%13Analyst ForecastAnalyst Revision0.34%ACADACADIA Pharmaceuticals$17.19+0.9%4.1483 of 5 stars2.50$23.93 39.2%16News Coverage0.33%CPRXCatalyst Pharmaceuticals$24.84-1.2%4.839 of 5 stars3.13$32.29 30.0%8Analyst RevisionPositive News0.33%VERAVera Therapeutics$26.52+2.4%3.1435 of 5 stars3.20$64.67 143.8%10Positive News0.32%NTLAIntellia Therapeutics$8.40+1.1%4.4758 of 5 stars2.63$37.56 347.1%19Analyst Revision0.32%SNDXSyndax Pharmaceuticals$13.56+3.3%3.6696 of 5 stars2.90$36.20 167.0%100.31%IDYAIDEAYA Biosciences$17.43-0.1%3.5022 of 5 stars2.93$53.58 207.4%15News CoveragePositive News0.30%APGEApogee Therapeutics$39.25-2.2%2.428 of 5 stars3.00$92.17 134.8%6Positive News0.30%AGIOAgios Pharmaceuticals$30.84+1.4%4.3547 of 5 stars2.56$56.57 83.4%9Short Interest ↓Positive News0.30%IMVTImmunovant$18.79+5.0%2.4884 of 5 stars3.00$41.00 118.2%100.29%DNLIDenali Therapeutics$14.20+2.8%4.4322 of 5 stars2.94$37.20 162.0%18Positive News0.29%CDNACareDx$18.35+0.7%3.3668 of 5 stars2.57$31.83 73.5%7Positive News0.28%CGONCG Oncology$26.94+1.5%1.3788 of 5 stars3.10$63.88 137.1%10Analyst ForecastNews Coverage0.28%ARWRArrowhead Pharmaceuticals$13.80-0.9%3.4603 of 5 stars2.60$41.44 200.3%100.27%GERNGeron$1.65-2.9%4.4624 of 5 stars2.82$5.75 248.5%11Short Interest ↓0.27%DYNDyne Therapeutics$11.80+4.8%3.2074 of 5 stars3.07$47.46 302.2%150.27%IOVAIovance Biotherapeutics$3.63+5.5%4.3204 of 5 stars2.88$20.25 457.9%8Analyst Revision0.27%MIRMMirum Pharmaceuticals$46.08-0.4%4.3893 of 5 stars3.09$58.20 26.3%110.26%KYMRKymera Therapeutics$30.20-0.6%1.539 of 5 stars2.87$56.36 86.6%15Positive News0.26%VCELVericel$46.07-0.8%3.2481 of 5 stars3.00$62.29 35.2%7Positive News0.24%BCRXBioCryst Pharmaceuticals$7.83+0.4%4.3774 of 5 stars2.86$15.57 98.9%7Short Interest ↑0.23%SPRYARS Pharmaceuticals$12.63+0.2%3.3221 of 5 stars3.17$31.00 145.4%6Earnings ReportAnalyst Revision0.22%CAPRCapricor Therapeutics$11.81-10.4%1.8496 of 5 stars3.00$34.50 192.1%6Analyst Revision0.22%JANXJanux Therapeutics$29.78-1.1%3.4453 of 5 stars3.08$92.44 210.4%12Positive News0.22%IBRXImmunityBio$3.36+20.9%2.0948 of 5 stars3.00$12.19 262.7%5High Trading Volume0.22%MNKDMannKind$5.10+0.8%2.4462 of 5 stars3.13$9.21 80.7%80.22%MYGNMyriad Genetics$9.22+0.1%4.1698 of 5 stars2.20$21.89 137.4%15Analyst UpgradePositive News0.21%NRIXNurix Therapeutics$12.55-1.4%2.0467 of 5 stars2.83$30.88 146.1%18Positive News0.21%GRALGrail$28.58+0.7%0.7653 of 5 stars2.00$20.00 -30.0%3Positive News0.20%IRONDisc Medicine$52.470.0%2.9653 of 5 stars3.09$93.80 78.8%11Insider Trade0.19%DAWNDay One Biopharmaceuticals$8.19+0.9%2.8159 of 5 stars3.13$32.29 294.2%8Analyst Forecast0.19%SYRESpyre Therapeutics$17.69+3.9%2.0298 of 5 stars3.13$50.33 184.5%8News Coverage0.18%RCKTRocket Pharmaceuticals$7.88+2.5%4.6697 of 5 stars2.92$43.00 445.7%12Positive News0.17%PRAXPraxis Precision Medicines$38.85+1.7%2.531 of 5 stars2.78$123.33 217.5%9Positive News0.16%COGTCogent Biosciences$6.61+2.2%2.4062 of 5 stars2.75$14.43 118.3%8Positive News0.16%ANABAnaptysBio$18.65+2.5%2.9951 of 5 stars2.73$35.11 88.3%11Buyback AnnouncementNews CoverageHigh Trading Volume0.15%PRTAProthena$13.01-2.7%3.3706 of 5 stars2.75$55.00 322.8%8Analyst RevisionNews CoveragePositive News0.14%KURAKura Oncology$7.144.3133 of 5 stars2.92$25.50 257.1%12Analyst Upgrade0.13%REPLReplimune Group$10.45+0.5%3.8514 of 5 stars3.13$19.43 85.9%8Positive News0.12%RLAYRelay Therapeutics$2.99+4.5%2.2705 of 5 stars2.90$19.80 562.2%10News Coverage0.12%VIRVir Biotechnology$6.67+1.2%3.6019 of 5 stars2.83$35.67 434.7%60.11%CGEMCullinan Therapeutics$8.29+2.5%2.2031 of 5 stars3.00$32.86 296.3%8Positive News This page (NYSEARCA:LABU) was last updated on 3/27/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bull 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bull 3x Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
